Pure Global AI
Registration holder profile

CEPALAB LABORATÓRIOS LTDA

Brazil132 ANVISA registrations65 unique technical categoriesJan 12, 2015 – Sep 08, 2022
132
Total products
65
Technical names
Jan 2015
Earliest registration
Sep 2022
Latest registration
Regulatory footprint
Search CEPALAB LABORATÓRIOS LTDA across other regulatory registries
Recent registrations
Latest 5 products registered by this holder
Most popular products
Products with most registrations
Top manufacturers
Manufacturers with the most products registered by this holder
Products per risk level
Distribution of distinct commercial products by ANVISA risk classification
Class I23Distinct Products · 25 total registrations
Class II83Distinct Products · 91 total registrations
Class III16Distinct Products · 16 total registrations
About this profile

Access comprehensive registration holder profile for CEPALAB LABORATÓRIOS LTDA through Pure Global AI's free Brazil medical device database. This registration holder manages 132 medical device registrations with ANVISA across 65 unique technical categories. Their regulatory portfolio spans from Jan 12, 2015 to Sep 08, 2022.

This page provides comprehensive insights including 5 recent product registrations with the latest being Lancets (AUTOLANCETA), 5 most popular products led by SELF-TEST FOR HUMAN CHORIONIC GONADOTROPIN (HCG) with 13 registrations, partnerships with 5 key manufacturers including GUANGZHOU WONDFO BIOTECH CO., LTD. and GUANGZHOU WONDFO BIOTECH CO. LTD, and products across 3 risk classifications with 23 Class I devices. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping distributors understand market dynamics and identify business opportunities.